Your browser doesn't support javascript.
loading
The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem/progenitor cells.
Pellicano, F; Simara, P; Sinclair, A; Helgason, G V; Copland, M; Grant, S; Holyoake, T L.
Affiliation
  • Pellicano F; Paul O'Gorman Leukaemia Research Centre, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Leukemia ; 25(7): 1159-67, 2011 Jul.
Article in En | MEDLINE | ID: mdl-21483442
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Benzamides / Benzodiazepines / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid, Chronic-Phase / Blast Crisis / Apoptosis / MAP Kinase Kinase Kinases / Enzyme Inhibitors / Farnesyltranstransferase Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2011 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Benzamides / Benzodiazepines / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid, Chronic-Phase / Blast Crisis / Apoptosis / MAP Kinase Kinase Kinases / Enzyme Inhibitors / Farnesyltranstransferase Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2011 Document type: Article Affiliation country: Country of publication: